Log in

Revolution Medicines Stock Forecast, Price & News

+0.10 (+0.30 %)
(As of 09/29/2020 12:00 AM ET)
Today's Range
Now: $33.97
50-Day Range
MA: $28.48
52-Week Range
Now: $33.97
Volume388,447 shs
Average Volume363,272 shs
Market Capitalization$2.24 billion
P/E RatioN/A
Dividend YieldN/A
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit targets primarily within the RAS and mTOR signaling pathways. The company's principal product candidate is RMC-4630, an inhibitor of SHP2, which is in Phase 1b/2 study for the treatment of RAS-dependent tumors. Its products in preclinical stage include mutant RAS proteins; SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a mTORC1 inhibitor. Revolution Medicines, Inc. has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors. The company was founded in 2014 and is headquartered in Redwood City, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:RVMD



Sales & Book Value

Annual Sales$50.04 million



Market Cap$2.24 billion
Next Earnings Date11/9/2020 (Estimated)
OptionableNot Optionable
+0.10 (+0.30 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RVMD News and Ratings via Email

Sign-up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Revolution Medicines (NASDAQ:RVMD) Frequently Asked Questions

How has Revolution Medicines' stock been impacted by Coronavirus (COVID-19)?

Revolution Medicines' stock was trading at $29.67 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RVMD shares have increased by 14.5% and is now trading at $33.97.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Revolution Medicines?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Revolution Medicines in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Revolution Medicines

When is Revolution Medicines' next earnings date?

Revolution Medicines is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Revolution Medicines

How were Revolution Medicines' earnings last quarter?

Revolution Medicines, Inc (NASDAQ:RVMD) announced its earnings results on Monday, August, 10th. The company reported ($0.46) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.10. The firm had revenue of $10.03 million for the quarter, compared to the consensus estimate of $13.20 million.
View Revolution Medicines' earnings history

What price target have analysts set for RVMD?

5 Wall Street analysts have issued twelve-month price objectives for Revolution Medicines' stock. Their forecasts range from $32.00 to $52.00. On average, they expect Revolution Medicines' stock price to reach $43.25 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts' price targets for Revolution Medicines

Who are some of Revolution Medicines' key competitors?

What other stocks do shareholders of Revolution Medicines own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Revolution Medicines investors own include Alector (ALEC), Editas Medicine (EDIT), Homology Medicines (FIXX), Gossamer Bio (GOSS), Livongo Health (LVGO), Sorrento Therapeutics (SRNE), I-Mab (BDTX), Beam Therapeutics (BEAM), Crowdstrike (CRWD) and Precision BioSciences (DTIL).

Who are Revolution Medicines' key executives?

Revolution Medicines' management team includes the following people:
  • Dr. Mark A. Goldsmith M.D., Ph.D., CEO, Pres & Chairman (Age 58, Pay $506.3k)
  • Ms. Margaret A. Horn, COO & Gen. Counsel (Age 57, Pay $386.38k)
  • Dr. Stephen M. Kelsey M.D., FRCP, FRC Path., Pres of R&D (Age 59, Pay $426.35k)
  • Dr. Martin D. Burke, Co-Founder & Chairman of Scientific Advisory Board
  • Dr. Michael A. Fischbach, Academic Co-Founder & Member of Scientific Advisory Board (Age 39)

When did Revolution Medicines IPO?

(RVMD) raised $150 million in an initial public offering (IPO) on Thursday, February 13th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen, SVB Leerink and Guggenheim Securities served as the underwriters for the IPO.

What is Revolution Medicines' stock symbol?

Revolution Medicines trades on the NASDAQ under the ticker symbol "RVMD."

When did the company's lock-up period expire?

Revolution Medicines' lock-up period expired on Tuesday, August 11th. Revolution Medicines had issued 14,000,000 shares in its initial public offering on February 13th. The total size of the offering was $238,000,000 based on an initial share price of $17.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.

How do I buy shares of Revolution Medicines?

Shares of RVMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Revolution Medicines' stock price today?

One share of RVMD stock can currently be purchased for approximately $33.97.

How big of a company is Revolution Medicines?

Revolution Medicines has a market capitalization of $2.24 billion and generates $50.04 million in revenue each year. Revolution Medicines employs 100 workers across the globe.

What is Revolution Medicines' official website?

The official website for Revolution Medicines is www.revmed.com.

How can I contact Revolution Medicines?

Revolution Medicines' mailing address is 700 Saginaw Drive, Redwood City CA, 94063. The company can be reached via phone at 650-481-6801 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.